Glycosaminoglycan and cationic polymer combinations

Claim 2

A combination comprising: (1) glycosaminoglycan; and (2) cationic polymer selected from the group consisting water-soluble of cationic derivatives of cellulose ethers, galactomannan, homo- and copolymers of ethylenically unsaturated compounds and poly(N-acylalkyleneimines); which combination provides modification of the glycosaminoglycan properties due to the presence of the cationic polymer.

Claim 3

The combination of claim 1 wherein the glycosaminoglycan is hyaluronan, hylan or other hyaluronan derivative.

Claim 4

The combination of claim 2 wherein the glycosaminoglycan is an acid or salt of hyaluronan, hylan or other hyaluronan derivative, a mixture of hyaluronan with proteins and naturally occurring substances derived by the production of hyaluronan from natural material, or mixtures of such materials.

Claim 5

The combination of claim 3 wherein the glycosaminoglycan is an alkali metal or alkaline earth metal salt of hyaluronan, hylan or other hyaluronan derivative.

Claim 6

The combination of claim 1 wherein the cationic polymer is a cellulose ether represented by the overall structural formula: ##STR9## wherein: R cell is the residue of an anhydroglucose repeat unit; z is from 50 to about 20,000; and each R 1 , R 2 and R 3 is individually represented by the substituent structural formula: ##STR10## wherein: A is an anion; a is an integer of from 1 to about 3; m is an integer of from 0 to about 6; n is an integer greater than or equal to 0, provided that the level of cationic substitution, CS, defined by the average moles of quaternary nitrogen atoms per mole anhydroglucose repeat unit is greater than 0; p is an integer of from 0 to about 6; q is 0 or 1; each R 5 and R 7 is individually ethylene, a propylene or a hydroxypropylene; R 6 is a di- or trivalent, cyclic, branched or straight chain, saturated or unsaturated hydrocarbon having from 2 to about 6 carbon atoms, provided there are at least 2 carbon atoms between the nitrogen atom and any oxygen atom; R 8 is hydrogen, hydroxyl, R h , alkyl, carboxyl or alkali metal or amine carboxylate, or other terminal group provided that when q is 0 then R 8 is hydrogen or alkyl; each R 9 , R 10 and R 11 is individually R h , alkyl, aryl, aralkyl, alkaryl, cycloalkyl, alkoxyaryl or alkoxyalkyl, having at least two carbon atoms separating the oxygen atom in the alkoxyaryl or alkoxyalkyl group from the nitrogen atom or together with R 6 forms a heterocyclic ring; R h is a hydrophobic group containing an alkyl group having at least 8 carbon atoms; v is equal to the valence of A; y is 0 or 1, provided that when y is 0 then p and q are 0 and R 8 is hydrogen or other terminal group.

Claim 7

The combination of claim 5 wherein the cellulose ether is polyquaternium-4, polyquaternium-10 or such cellulose ethers containing hydrophobic groups including polyquaternium-24.

Claim 8

The combination of claim 6 wherein the glycosaminoglycan is hyaluronan, hylan or other hyaluronan derivative.

Claim 9

A substantive combination of claim 1 wherein the glycosaminoglycan is substantive to keratinous material.

Claim 10

The combination of claim 8 having a relative weight ratio of cationic polymer to glycosaminoglycan which provides an enhanced degree of glycosaminoglycan substantivity.

Claim 11

The combination of claim 9 wherein the relative weight ratio of cationic polymer to glycosaminoglycan provides enhanced glycosaminoglycan substantivity to skin and is greater than about 5:1.

Claim 12

The combination of claim 9 wherein the relative weight ratio of cationic polymer to glycosaminoglycan provides enhanced glycosaminoglycan substantivity to hair and is from about 5:1 to about 25:1.

Claim 13

A compatible combination of claim 1 which provides an aqueous solution substantially free of precipitate.

Claim 14

A stable combination of claim 1 which provides an aqueous solution substantially free of precipitation or significant reduction in viscosity over a period of four months at 4° C.

Claim 15

A rheologically modified combination of claim 1 having a viscosity, elasticity or other rheological property of the glycosaminoglycan modified by the presence of the cationic polymer.

Claim 16

The combination of claim 14 wherein the glycosaminoglycan provides enhanced feel properties.

Claim 17

The combination of claim 1 wherein the relative weight ratio of cationic polymer to glycosaminoglycan is from about 0.01:1 to about 200:1.

Claim 18

The combination of claim 16 wherein the relative weight ratio of cationic polymer to glycosaminoglycan is from about 10:1 to about 50:1.

Claim 19

A hair or skin care composition or combination of compositions comprising the glycosaminoglycan and cationic polymer combination of claim 1 in one or more distinct formulations containing suitable hair or skin care ingredients.

Claim 20

A medical composition or combination of compositions comprising the glycosaminoglycan and cationic polymer combination of claim 1 in one or more distinct formulations containing suitable medical ingredients.

Claim 21

A combination comprising hyaluronan or derivative thereof and water-soluble, quaternary nigrogen-containing cellulose ether represented by the overall structural formula: ##STR11## wherein: R cell is the residue of an anhydroglucose repeat unit; z is from 50 to about 20,000; and each R 1 , R 2 and R 3 is individually represented by the substituent structural formula: ##STR12## wherein: A is an anion; a is an integer of from 1 to about 3; m is an integer of from 0 to about 6; n is an integer greater than or equal to 0, provided that the level of cationic substitution, CS, defined by the average moles of quaternary nitrogen atoms per mole anhydroglucose repeat unit is greater than 0; p is an integer of from 0 to about 6; q is 0 or 1; each R 5 and R 7 is individually ethylene, a propylene or a hydroxypropylene; R 6 is a di- or trivalent, cyclic, branched or straight chain, saturated or unsaturated hydrocarbon having from 2 to about 6 carbon atoms, provided there are at least 2 carbon atoms between the nitrogen atom and any oxygen atom; R 8 is hydrogen, hydroxyl, R h , carboxyl or alkali metal or amine carboxylate, or other terminal group provided that when q is 0 then R 8 is hydrogen or other terminal group; each R 9 , R 10 and R 11 is individually R h , alkyl, aryl, aralkyl, alkaryl, cycloalkyl, alkoxyaryl or alkoxyalkyl, having at least two carbon atoms separating the oxygen atom in the alkoxyaryl or alkoxyalkyl group from the nitrogen atom or together with R 6 forms a heterocyclic ring; R h is a hydrophobic group containing an alkyl group having at least 8 carbon atoms; v is equal to the valence of A; y is 0 or 1, provided that when y is 0 then p and q are 0 and R 8 is hydrogen or other terminal group; with the provisos that: (1) the extent of hydrophobic group substitution, HS, defined by the average moles of said hydrophobic groups per mole of anhydroglucose repeat unit, is greater than 0; or (2) any one of R 9 , R 10 or R 11 taken together with R 6 forms a heterocyclic ring and the average value of n per anhydroglucose repeat unit, is greater than 0.

Claim 22

A combination comprising hyaluronan or derivative thereof and water-soluble, quaternary nigrogen-containing cellulose ether represented by the overall structural formula: ##STR11## wherein: R cell is the residue of an anhydroglucose repeat unit; z is from 50 to about 20,000; and each R 1 , R 2 and R 3 is individually represented by the substituent structural formula: ##STR12## wherein: A is an anion; a is an integer of from 1 to about 3; m is an integer of from 0 to about 6; n is an integer greater than or equal to 0, provided that the level of cationic substitution, CS, defined by the average moles of quaternary nitrogen atoms per mole anhydroglucose repeat unit is greater than 0; p is an integer of from 0 to about 6; q is 0 or 1; each R 5 and R 7 is individually ethylene, a propylene or a hydroxypropylene; R 6 is a di- or trivalent, cyclic, branched or straight chain, saturated or unsaturated hydrocarbon having from 2 to about 6 carbon atoms, provided there are at least 2 carbon atoms between the nitrogen atom and any oxygen atom; R 8 is hydrogen, hydroxyl, R h , carboxyl or alkali metal or amine carboxylate, or other terminal group provided that when q is 0 then R 8 is hydrogen or other terminal group; each R 9 , R 10 and R 11 is individually R h , alkyl, aryl, aralkyl, alkaryl, cycloalkyl, alkoxyaryl or alkoxyalkyl, having at least two carbon atoms separating the oxygen atom in the alkoxyaryl or alkoxyalkyl group from the nitrogen atom or together with R 6 forms a heterocyclic ring; R h is a hydrophobic group containing an alkyl group having at least 8 carbon atoms; v is equal to the valence of A; y is 0 or 1, provided that when y is 0 then p and q are 0 and R 8 is hydrogen or other terminal group; with the provisos that: (1) the extent of hydrophobic group substitution, HS, defined by the average moles of said hydrophobic groups per mole of anhydroglucose repeat unit, is greater than 0; or (2) any one of R 9 , R 10 or R 11 taken together with R 6 forms a heterocyclic ring and the average value of n per anhydroglucose repeat unit, is greater than 0.

Claim 23

A process for modifying the properties of glycosaminoglycan which comprises combining glycosaminoglycan with an effective amount of cationic polymer.

Claim 24

A process for modifying the properties of glycosaminoglycan which comprises combining glycosaminoglycan with an effective amount of cationic polymer.

Claim 25

The process of claim 21 which comprises increasing the substantivity of the glycosaminoglycan to keratinous material.

Claim 26

The process of claim 22 which comprises enhancing the feel characteristics provided by the glycosaminoglycan.